These reports suggest that an unknown mechanism of cell-to-cell contact involving MHC-dependent signaling is required to regulate MDSCs in systemic and tumor microenvironments and that these mechanisms might induce different immune responses in xenograft and allograft tumor models [25,33]. The gene discussed is HLA-C; the disease is neoplasm.